MICHAEL ZUMAR: Open Payments
NPI 1992252134 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 19 payments from 8 companies in 2025. Trend: 2023 $36 · 2024 $222 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 10 | $189 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $59 |
| Abbott Laboratories | 1 | $27 |
| Impulse Dynamics (USA) Inc. | 1 | $26 |
| Solventum Corporation | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: Assure WCD, LifeVest, CARDIOMEMS, Optimizer, V.A.C.ULTA, VYNDAQEL, JARDIANCE, FARXIGA.
Industry payments across PA — which companies pay providers there.
